Device for closure of atrial septal defects
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
376
NCT04105595
Post Market Registry of the CBSO
Phase: N/A
Role: Lead Sponsor
Start: Mar 5, 2020
Completion: Oct 31, 2024
NCT04591392
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
Start: Mar 12, 2021
Completion: Mar 31, 2032
NCT05725954
GUT LINK: A Study of a Care Pathway Across Primary and GI Specialty Care
Start: Feb 1, 2024
Completion: Dec 31, 2026
Loading map...